Question 1

Does Tudor Investment own ALXN stock?

Accepted Answer

As of its Q2 2021 13F, Tudor Investment held 907,855 shares of ALXN (Alexion Pharmaceuticals), worth $166.8M.

Question 2

How many shares of ALXN does Tudor Investment own?

Accepted Answer

As of its Q2 2021 13F, Tudor Investment held 907,855 shares of ALXN (Alexion Pharmaceuticals).

Question 3

What is Tudor Investment's ALXN position worth?

Accepted Answer

As of its Q2 2021 13F, Tudor Investment's ALXN position was worth $166.8M.

Question 4

When did Tudor Investment first buy ALXN?

Accepted Answer

Tudor Investment already held ALXN in its Q4 2018 13F, the earliest on record, and listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q2	Increased	907,855	+72.0%	$166.8M	3.2%	—	83
2021-Q1	Increased	527,741	+58.3%	$80.7M	1.6%	—	67
2020-Q4	Increased	333,377	+363.0%	$52.1M	1.5%	—	75
2020-Q3	Increased	72,000	+267.4%	$8.2M	0.4%	—	53
2020-Q2	Decreased	19,595	-18.7%	$2.2M	0.1%	—	0
2020-Q1	Decreased	24,097	-64.0%	$2.2M	0.2%	—	0
2019-Q4	Decreased	66,970	-24.8%	$7.2M	0.3%	—	0
2019-Q3	Increased	89,071	+45.4%	$8.7M	0.3%	—	45
2019-Q2	Increased	61,254	+246.9%	$8M	0.2%	—	53
2019-Q1	Decreased	17,655	-47.4%	$2.4M	0.1%	—	0
2018-Q4	First report	33,592	-	$3.3M	0.1%	—	0

ALXN12 quarters

ALXN
12 quarters